Amicus Therapeutics Inc Strategic Asset Allocation Index
Amicus Therapeutics Inc strategic asset allocation index. Amicus Therapeutics Inc (FOLD) has a Strategic Asset Allocation Index of 45.5% as of September 2023. Strategic assets (PP&E of $60.58 Million plus long-term investments of $-) total $60.58 Million, measured against net assets of $133.24 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See FOLD net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Amicus Therapeutics Inc (2004–2022)
Strategic asset allocation index of Amicus Therapeutics Inc from 2004 to 2022. This chart shows how Amicus Therapeutics Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2004 to 2022. As of September 2023, the index stands at 45.5%, representing strategic assets of $60.58 Million against net assets of $133.24 Million USD. Check Amicus Therapeutics Inc (FOLD) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Amicus Therapeutics Inc Strategic Asset Allocation Index by Year (2004–2022)
Amicus Therapeutics Inc strategic asset allocation index by year from 2004 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Amicus Therapeutics Inc from 2004 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Amicus Therapeutics Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.0% | $30.78 Million | $30.78 Million | $- | $123.05 Million | ▲ +11.2 pp |
| 2021 | 13.8% | $42.50 Million | $42.50 Million | $- | $307.37 Million | ▼ -1.5 pp |
| 2020 | 15.3% | $43.86 Million | $43.86 Million | $- | $286.38 Million | ▲ +5.3 pp |
| 2019 | 10.0% | $47.70 Million | $47.70 Million | $- | $476.43 Million | ▲ +6.7 pp |
| 2018 | 3.3% | $11.38 Million | $11.38 Million | $- | $342.91 Million | ▲ +0.7 pp |
| 2017 | 2.6% | $9.06 Million | $9.06 Million | $- | $352.85 Million | ▼ -0.2 pp |
| 2016 | 2.7% | $9.82 Million | $9.82 Million | $- | $360.15 Million | ▲ +0.9 pp |
| 2015 | 1.8% | $6.18 Million | $6.18 Million | $- | $347.83 Million | ▼ -14.8 pp |
| 2014 | 16.6% | $20.27 Million | $2.81 Million | $17.46 Million | $122.18 Million | ▲ +7.6 pp |
| 2013 | 9.0% | $4.12 Million | $4.12 Million | $- | $45.75 Million | ▲ +1.7 pp |
| 2012 | 7.3% | $5.03 Million | $5.03 Million | $- | $69.22 Million | ▼ -1.0 pp |
| 2011 | 8.2% | $2.44 Million | $2.44 Million | $- | $29.59 Million | ▲ +4.2 pp |
| 2010 | 4.0% | $2.60 Million | $2.60 Million | $- | $64.93 Million | ▼ -2.1 pp |
| 2009 | 6.1% | $4.40 Million | $4.40 Million | $- | $71.83 Million | ▼ -0.8 pp |
| 2008 | 6.9% | $4.92 Million | $4.92 Million | $- | $71.04 Million | ▲ +3.3 pp |
| 2007 | 3.7% | $3.79 Million | $3.79 Million | $- | $103.30 Million | ▼ -9.4 pp |
| 2004 | 13.0% | $541.00K | $541.00K | $- | $4.15 Million | — |